MENU
BEAM
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Beam Therapeutics (BEAM) Ownership - Who owns Beam Therapeutics?

Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases... Show more

Profile

Industry
N/A
Address
238 Main Street
Phone
+1 857 327-8775
Employees
511
Web
https://www.beamtx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
3.51B
P/E Ratio
N/A
Total Cash
1.21B
Projected Growth
N/A
Total Debt
250.82M
Revenue
164.01M
Risk (Beta)
2.88
Dividend Yield
N/A
Total Cash/Share
11.78
Total Debt/Equity
N/A
Revenue/Share
1.60 USD as % of share price
View a ticker or compare two or three
BEAM
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a company, which develops and commercializes DNA base editing technologies for the treatment of human disease.

Industry Biotechnology

Profile
Details
Industry
N/A
Address
238 Main Street
Phone
+1 857 327-8775
Employees
511
Web
https://www.beamtx.com